中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Iridium-Catalyzed Asymmetric Hydrogenation of 3-Substituted 2H-1,4-Benzoxazines

文献类型:期刊论文

作者Gao, Kai1; Yu, Chang-Bin1; Wang, Duo-Sheng1; Zhou, Yong-Gui1,2
刊名advanced synthesis & catalysis
出版日期2012-02-01
卷号354期号:2-3页码:483-488
关键词asymmetric hydrogenation benzoxazines chiral amines cyclic imines iridium
英文摘要the highly enantioselective hydrogenation of 3-aryl-2h-1,4-benzoxazines was achieved using the (cyclooctadiene)iridium chloride dimer/(s)-segphos/iodine {[ir(cod)cl]2/(s)-segphos/i2} system as catalyst with up to 92% ee. the 3-styryl-2h-1,4-benzoxazine derivatives were also hydrogenated by the iridium catalyst and pd/c in two consecutive steps whereby 9395% ee values were obtained.
WOS标题词science & technology ; physical sciences
类目[WOS]chemistry, applied ; chemistry, organic
研究领域[WOS]chemistry
关键词[WOS]highly enantioselective hydrogenation ; n-aryl imines ; kinetic resolution ; heteroaromatic-compounds ; reductive amination ; key intermediate ; acyclic imines ; cyclic imines ; complexes ; quinolines
收录类别SCI ; IC
语种英语
WOS记录号WOS:000300448400029
公开日期2015-11-17
源URL[http://159.226.238.44/handle/321008/143097]  
专题大连化学物理研究所_中国科学院大连化学物理研究所
作者单位1.Chinese Acad Sci, State Key Lab Catalysis, Dalian Inst Chem Phys, Dalian 116023, Peoples R China
2.Chinese Acad Sci, State Key Lab Organometall Chem, Shanghai Inst Organ Chem, Shanghai 200032, Peoples R China
推荐引用方式
GB/T 7714
Gao, Kai,Yu, Chang-Bin,Wang, Duo-Sheng,et al. Iridium-Catalyzed Asymmetric Hydrogenation of 3-Substituted 2H-1,4-Benzoxazines[J]. advanced synthesis & catalysis,2012,354(2-3):483-488.
APA Gao, Kai,Yu, Chang-Bin,Wang, Duo-Sheng,&Zhou, Yong-Gui.(2012).Iridium-Catalyzed Asymmetric Hydrogenation of 3-Substituted 2H-1,4-Benzoxazines.advanced synthesis & catalysis,354(2-3),483-488.
MLA Gao, Kai,et al."Iridium-Catalyzed Asymmetric Hydrogenation of 3-Substituted 2H-1,4-Benzoxazines".advanced synthesis & catalysis 354.2-3(2012):483-488.

入库方式: OAI收割

来源:大连化学物理研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。